Abstract
Background Parkinson’s disease (PD) is marked by a loss of motor automaticity, resulting in decreased control of step length during gait. Rhythmic auditory cues (metronomes or music) may enhance automaticity by adjusting cadence. Both metronomes and music may offer distinct advantages, but prior attempts at quantifying their influence on spatiotemporal aspects of gait have been confounded by altered gait speeds from overground walking. We hypothesized that when gait speed is fixed, individuals with PD would experience difficulty in modifying cadence due to the concomitant requirement to alter step length, with greater changes noted with metronomes compared to music cues.
Research Question Can a metronome or music promote spatiotemporal adjustments when decoupled from changes in gait speed in individuals with PD?
Methods 21 participants with PD were instructed to time their steps to a metronome and music cues (at 85%, 100%, and 115% of overground cadence) during treadmill walking. We calculated cadence, cadence accuracy, and step length during each cue condition and an uncued control condition. We compared the various cue frequencies and auditory modalities.
Results At fixed gait speeds, participants were able to increase and decrease cadence in response to auditory cues. Music and metronome cues produced comparable results in cadence manipulation with greater cadence errors noted at slower intended frequencies. Nevertheless, the induced cadence changes created a concomitant alteration in step length, with music and metronomes producing comparable changes. Notably, longer step lengths were induced with both music and metronome during slow frequency cueing.
Significance This important change conflicts with conventional prescriptive approaches, which advocate for faster cue frequencies, if applied on a treadmill. The music and metronome cues produced comparable changes to gait, suggesting that either cue may be effective at overcoming the shortened step lengths during treadmill walking if slower frequencies are used.
Competing Interest Statement
Nina Browner has received travel and speaker fees from Parkinson Foundation and a grant for Parkinson Foundation Center of Excellence at University of North Carolina at Chapel Hill. For the remaining authors none are declared.
Clinical Trial
NCT03253965
Funding Statement
No external funding was received for this study.
Author Declarations
All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.
Yes
Footnotes
Conflicts of Interest Disclosure: Nina Browner has received travel and speaker fees from Parkinson Foundation and a grant for Parkinson Foundation Center of Excellence at University of North Carolina at Chapel Hill. For the remaining authors none are declared.
These data were presented in abstract form at the Combined Sections Meeting of the APTA, Washington, DC, January 2019
Data Availability
Data will be made available upon request.
